Tom van Aken

Chief Executive Officer
Molecular Biology
Avantium Pharma
Netherlands

Business Expert Molecular Biology
Biography

T. B. Van Aken has been Chief Executive Officer of the Company (CEO) since February 2006 (effective as of December 2005). In 2002, he joined the Company as Vice President of Business Development. In March 2004, he became Vice President of Global Marketing & Sales and a member of the Management Board, followed by his appointment as CEO per December 2005. Before joining the Group, Mr. Van Aken held numerous commercial positions at DSM in the Netherlands and in New Jersey, United States. Mr. Van Aken holds a master’s degree in chemistry from Utrecht University.  

Research Intrest

 Molecular Chemistry